The PEGS (Protein & Antibody Engineering) Boston Summit is a leading annual conference that brings together scientists, biotech and pharma leaders, and researchers to share advances in biologics, protein engineering, and antibody research. This event features hundreds of presentations, training courses, and networking opportunities covering topics such as antibody and protein design, immunotherapy, bispecifics, AI/ML for biologics, and analytical characterization. It’s widely regarded as a key forum for learning about cutting-edge science, practical R&D strategies, and emerging technologies shaping the future of biologic drug development.

https://www.pegsummit.com/

Date: May 11-15, 2026
Location: Omni Boston Hotel at the Seaport, Boston, Massachusetts
Booth: 806

JOIN US!

Join Catalent at PEGS US in Boston this May, where our experts will be on hand to discuss how our integrated biologics development and manufacturing capabilities help accelerate complex protein programs from discovery to commercialization.

Meet us at our booth throughout the conference and attend our featured presentation to learn how we’re advancing higher yield, higher quality protein production workflows.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Valeria Guzman, Associate Principal Scientist, Process Development, Downstream
Date/Time: Friday, May 15^th, 2026, at 10:00 a.m. | Maximizing Protein Production Workflows
Title: From Complexity to Consistency: High‑Throughput Screening Strategies for Scalable Multispecific Antibody Development

Speaker: Amruta Mhashilkar, Associate Director, Formulation & Process Development
Date/Time: Thursday, May 14^th, 2026 at 3:40pm
Title: Breaking the Injection Barrier: Overcoming Challenges to Oral Delivery of Peptides

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™